Gamorez, Aldin R.

HRN: 23-12-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/31/2023
06/07/2023
IV
3ml
Bid
Pcap C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: